CVE-2020-27260
CVE-2020-27260 is a medium-severity vulnerability in Innokasmedical Vital Signs Monitor Vc150 Firmware with a CVSS 3.x base score of 5.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-74.
Key facts
- Severity: Medium (CVSS 3.x base score 5.3)
- CVSS v2: 2.1
- EPSS exploit prediction: 0% (35th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-74
- Affected product: Innokasmedical Vital Signs Monitor Vc150 Firmware
- Published:
- Last modified:
Description
Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 HL7 v2.x injection vulnerabilities exist in the affected products that allow physically proximate attackers with a connected barcode reader to inject HL7 v2.x segments into specific HL7 v2.x messages via multiple expected parameters.
Frequently asked questions
- What is CVE-2020-27260?
- Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 HL7 v2.x injection vulnerabilities exist in the affected products that allow physically proximate attackers with a connected barcode reader to inject HL7 v2.x segments into specific HL7 v2.x messages via multiple expected parameters.
- How severe is CVE-2020-27260?
- CVE-2020-27260 has a CVSS 3.x base score of 5.3, rated medium severity. It is exploitable over physical access with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability none.
- Is CVE-2020-27260 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (35th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2020-27260?
- CVE-2020-27260 affects Innokasmedical Vital Signs Monitor Vc150 Firmware. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2020-27260?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- When was CVE-2020-27260 published?
- CVE-2020-27260 was published on 2021-01-08 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:o:innokasmedical:vital_signs_monitor_vc150_firmware:*:*:*:*:*:*:*:*
More vulnerabilities in Innokasmedical Vital Signs Monitor Vc150 Firmware
- CVE-2020-27262 — Medium (CVSS 5.4): Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 A stored cross-site scripting (XSS) vulnerability…
All CVEs affecting Innokasmedical Vital Signs Monitor Vc150 Firmware →
Other CWE-74 (Improper Neutralization of Special Elements (Injection)) vulnerabilities
- CVE-2026-25586 — Critical (CVSS 10.0): SandboxJS is a JavaScript sandboxing library. Prior to 0.8.29, a sandbox escape is possible by shadowing hasOwnProperty…
- CVE-2026-25520 — Critical (CVSS 10.0): SandboxJS is a JavaScript sandboxing library. Prior to 0.8.29, The return values of functions aren't wrapped.…
- CVE-2025-20265 — Critical (CVSS 10.0): A vulnerability in the RADIUS subsystem implementation of Cisco Secure Firewall Management Center (FMC) Software could…
- CVE-2025-20337 — Critical (CVSS 10.0): A vulnerability in a specific API of Cisco ISE and Cisco ISE-PIC could allow an unauthenticated, remote attacker to…
- CVE-2025-20281 — Critical (CVSS 10.0): A vulnerability in a specific API of Cisco ISE and Cisco ISE-PIC could allow an unauthenticated, remote attacker to…
- CVE-2024-42472 — Critical (CVSS 10.0): Flatpak is a Linux application sandboxing and distribution framework. Prior to versions 1.14.0 and 1.15.10, a malicious…
Browse all CWE-74 (Improper Neutralization of Special Elements (Injection)) vulnerabilities →